What is Kikuchi disease, including its definition, clinical presentation, diagnosis, and treatment options?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Kikuchi Disease: Comprehensive Overview

Definition

Kikuchi-Fujimoto disease (KFD) is a rare, benign, self-limiting histiocytic necrotizing lymphadenitis that predominantly affects young adults, characterized by tender cervical lymphadenopathy and fever. 1, 2 The disease is also known as histiocytic necrotizing lymphadenitis and was first described in Japan, though cases are now reported worldwide 3.

Epidemiology & Demographics

  • Age: Predominantly affects young adults, though cases occur across age ranges including middle-aged adults 1
  • Gender: More common in females 2
  • Ethnicity: Initially recognized in Oriental-Asian populations, but now documented globally 2
  • Recurrence: Can relapse even after prolonged asymptomatic periods (documented up to 9 years after initial diagnosis) 3

Etiology & Pathogenesis

The exact cause remains uncertain, but several associations have been identified:

  • Viral triggers: Epstein-Barr virus (EBV), herpes simplex virus (HSV), varicella-zoster virus (VZV) 4, 2
  • Autoimmune overlap: Systemic lupus erythematosus (SLE) and Sjögren's disease are the most common coexisting disorders 3, 2
  • Immune-mediated mechanism: An unidentified trigger initiates an inflammatory cascade in genetically susceptible individuals 3

Important caveat: Coexisting EBV infection does not exclude KFD and may occur simultaneously 4.

Clinical Presentation

Primary Features

  • Cervical lymphadenopathy: Tender, predominantly affecting posterior cervical lymph nodes (left-sided common) 1, 2
  • Fever: Low-grade to moderate, persistent 1, 4
  • Constitutional symptoms:
    • Night sweats
    • Weight loss
    • Malaise
    • Myalgia and arthralgia 4
    • Headaches 2

Duration

Symptoms typically persist for 2-6 weeks before diagnosis 1, 4

Imaging Findings

  • Ultrasound/CT: Multiple necrotic cervical lymph nodes, often with bilateral involvement 1
  • Multiple enlarged lymph nodes without suppuration 2

Laboratory Findings

Characteristic hematologic abnormalities include:

  • Normocytic anemia 4
  • Leukopenia (key finding) 4, 5
  • Elevated erythrocyte sedimentation rate (ESR) 4, 5
  • Abnormal liver function tests 4

Differential Diagnosis

KFD poses a significant diagnostic challenge due to its non-specific presentation. Critical differentials to exclude:

Infectious

  • Tuberculosis (most important to rule out)
  • Viral syndromes (EBV, CMV, others)
  • Bacterial lymphadenitis

Malignant

  • Lymphoma (Hodgkin's and non-Hodgkin's)
  • Leukemia
  • Metastatic disease

Autoimmune/Rheumatologic

  • Systemic lupus erythematosus (SLE)
  • Adult-onset Still's disease 6, 4
  • Sjögren's syndrome

Other

  • Sarcoidosis
  • Sweet's syndrome
  • Hemophagocytic syndrome 6

Common pitfall: The presentation can mimic bacterial lymphadenitis or lymphoma, leading to extensive workups and diagnostic delays averaging 14 days 4.

Diagnosis

Gold Standard

Excisional lymph node biopsy with histopathological examination 1, 2

Histopathological Features (Three Patterns)

  1. Proliferative type
  2. Necrotizing type (most common)
  3. Xanthomatous type

Characteristic findings:

  • Patchy areas of necrosis with karyorrhectic debris
  • Proliferation of histiocytes and immunoblasts
  • Absence of neutrophilic infiltration (key distinguishing feature) 1

Diagnostic Workup Algorithm

When to suspect KFD:

  • Persistent fever + cervical lymphadenopathy for >2 weeks
  • Negative tuberculosis screening (GeneXpert, Mantoux test, culture) 1
  • Negative infectious workup
  • Leukopenia with elevated ESR

Proceed to:

  1. Imaging (ultrasound/CT) to characterize lymph nodes
  2. Excisional lymph node biopsy (not fine needle aspiration—insufficient for diagnosis)
  3. Histopathological examination by experienced pathologist

Critical point: Reactive histologic findings at recurrence do not exclude KFD; interpret in context of prior confirmed disease and clinical evolution 3.

Treatment

First-Line Management

Symptomatic treatment with NSAIDs for pain relief 2, 5

Second-Line (Severe Cases)

Corticosteroids (tapering course) for:

  • Severe symptoms
  • Persistent fever
  • Significant constitutional symptoms 4, 2, 5

Additional Therapies for Refractory/Recurrent Cases

  • Hydroxychloroquine: May offer benefit in steroid-dependent or relapsing cases 3, 5
  • Anakinra: Emerging option for recurrent disease 3

Treatment approach for recurrent KFD:

  1. First-line: Corticosteroids (prednisone with taper)
  2. Steroid-dependent cases: Add hydroxychloroquine
  3. Relapsing cases: Consider anakinra (individualized, limited evidence)

Important limitation: No standardized protocols exist; treatments remain individualized interventions without controlled evidence 3.

Prognosis & Follow-Up

Natural History

  • Self-limited condition with spontaneous resolution typically within 1-4 months 2
  • Complete resolution of symptoms expected with symptomatic treatment 1

Recurrence Risk

  • Can relapse after unusually long latency (up to 9 years documented) 3
  • Recurrence may be associated with autoimmune features in selected cases 3
  • Requires renewed diagnostic vigilance even years after apparent resolution

Long-Term Monitoring

  • Follow-up for autoimmune disease development (particularly SLE and Sjögren's syndrome)
  • Monitor for recurrence, especially in first 2 years
  • No specific surveillance guidelines exist 4

Key Clinical Pearls

Diagnostic considerations:

  • Consider KFD when tuberculosis and malignancy workups are negative in cervical lymphadenopathy 1
  • Early histopathological diagnosis prevents misdiagnoses and unnecessary anxiety 4
  • Multidisciplinary approach with hematology consultation should be initiated early 4

Management pitfalls to avoid:

  • Do not rely on fine needle aspiration—excisional biopsy required
  • Do not dismiss diagnosis based on negative initial infectious workup
  • Do not assume permanent resolution—long-term recurrence possible
  • Do not overlook autoimmune screening, particularly for SLE

No specific national guidelines exist for KFD; management focuses on supportive care with escalation based on severity 4.

References

5
Research

Kikuchi Disease: A Case Report.

The Journal of emergency medicine, 2020

6
Guideline

diagnosis and management of adult onset still's disease.

Annals of the Rheumatic Diseases, 2006

Related Questions

What is the recommended steroid dosing regimen for an adult with severe Kikuchi disease (histiocytic necrotizing lymphadenitis)?
In a child with a history of Kawasaki disease who now has fever and cough without signs of recurrent Kawasaki disease, is it appropriate to start amoxicillin?
What are the clinical features and biochemical parameters of Kawasaki disease?
Can you provide a brief description of Kawasaki disease?
Are the left main coronary artery (LMCA), left anterior descending artery (LAD), left circumflex artery (LCX), and right coronary artery (RCA) given equal importance in Kawasaki disease?
In a patient with no personal or family history of cardiovascular disease but with elevated low‑density lipoprotein cholesterol, is it reasonable for the patient to be hesitant to start statin therapy because of diabetes risk, and what management strategies should be considered?
How should a 76‑year‑old woman with multinodular goitre on carbimazole, suppressed TSH, low‑normal T3 and a total T4 of 110.1 nmol/L (within the assay reference range 66–181 nmol/L) be managed endocrinologically before elective hip surgery?
Which of the following statements about aspirin is false? A) It irreversibly inhibits cyclooxygenase‑1. B) It has a proven benefit when administered to individuals with established cardiovascular disease. C) It increases the risk of gastrointestinal bleeding. D) Its antiplatelet effect lasts 7–10 days. E) Its administration at a dose of 75–100 mg daily is recommended for primary prevention in individuals at moderate cardiovascular risk.
In Omani pediatric patients receiving vancomycin with subtherapeutic trough levels, what are the likely causes and how should the dosing be adjusted?
What are the differential diagnoses for a two‑week rash involving the perioral area and genital region in an infant?
What is the appropriate management for persistent hypoglycemia in a newborn?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.